Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-05

Clinical Trial Update: The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating rotigotine for reducing signs and symptoms of fibromyalgia in adults; results were posted in January 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine (Neupro) (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Fibromyalgia Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2010-01-05